Evidence map›Paper›PMID 35642243›Full record

ArticlePatient preference and adherence2022

An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients' Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes.

Gérard Reach, Laurent Benarbia, Pierre-Yves Benhamou, Brigitte Delemer, Séverine Dubois, Didier Gouet, Bruno Guerci, Nathalie Jeandidier, Karim Lachgar, Gilles Le Pape and 8 more

Abstract read
In one paragraph

Article in Patient preference and adherence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. [Health education preferences in patients with type 2 diabetes mellitus based on Big Five personality traits].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Article
  2. Phenylketonuria as an Adherence Disease.Patient preference and adherence · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gérard ReachHealth Education and Promotion Laboratory (LEPS EA 3412), Sorbonne Paris Nord University, Bobigny, France.ORCID 0000-0001-6995-2665
Laurent BenarbiaMarketing Studio, Paris, France.
Pierre-Yves BenhamouDepartment of Endocrinology, Grenoble University Hospital; Grenoble Alpes University, INSERM U1055, LBFA, Grenoble, France.ORCID 0000-0003-4378-0468
Brigitte DelemerService d'Endocrinologie - Diabète - Nutrition, CHU de Reims - Hôpital Robert Debré, and Université de Reims Champagne Ardenne, UFR Sciences Exactes Et Naturelles, Reims, France.
Séverine DuboisDepartment of Diabetology and Endocrinology, CHU Angers, Angers, France.
Didier GouetDepartment of Diabetology and Endocrinology, Saint Louis Hospital, La Rochelle, France.
Bruno GuerciDepartment of Endocrinology, Diabetology and Nutrition, CHRU of Nancy, Brabois Hospital, and ILCV Lorraine University, Vandoeuvre-les-Nancy, France.
Nathalie JeandidierDepartment of Endocrinology, Diabetes and Nutrition, Hôpitaux Universitaires de Strasbourg, and Université de Strasbourg, Strasbourg, France.
Karim LachgarDepartment of Diabetology and Endocrinology, Centre Hospitalier Simone Veil, Eaubonne, France.
Gilles Le PapeGeneral Practice, Penmarc'h, France.ORCID 0000-0001-7849-3325
Rémy LeroyPrivate Medical Practice, Endocrinology and Diabetology, Lille, France.ORCID 0000-0002-7044-2694
Jean-Hugues MasgnauxM&M Conseil, Boulogne, France.
Philippe RacletAssociation Française des Diabétiques de Bourgogne Franche-Comté, Dijon, France.
Yves ReznikDepartment oEndocrinology and Diabetology, CHU Côte de Nacre, Caen, and University of Caen Basse-Normandie, Medical School, Caen, France.
Jean-Pierre RivelineDepartment of Diabetology and Endocrinology, Lariboisière Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Pauline SchaepelynckDepartment of Nutrition-Endocrinology-Metabolic Diseases, Pôle ENDO, APHM-Hôpital la Conception, Marseille, France.
Anne VambergueDepartment of Diabetology, Endocrinology, Metabolism and Nutrition, CHU Lille, and University Hospital European Genomic Institute for Diabetes, Lille, France.
Bruno VergèsDepartment of Endocrinology-Diabetology,CHU Dijon, and University of Burgundy, INSERM LNC UMR1231, Dijon, France.ORCID 0000-0001-8957-629X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Support programs are provided to people with diabetes to help them manage their disease. However, adherence to and persistence in support programs are often low, making it difficult to demonstrate their effectiveness. Aim: To identify the determinants of patients' perceived interest in diabetes support programs because it may be a powerful determinant of effective participation in such programs. Patients and Methods: An online study conducted in April 2021 in metropolitan France on 600 people with diabetes recruited from a consumer panel. A 64-item psychosocial questionnaire including a question asking to evaluate the helpfulness of a support program was used. Univariate, multivariate, and multiple correspondence analyses were performed. Results: The existence of a typology, known as Conclusion: This study describes this new

Indexed as

adherenceclinical outcomespatients’ expectationspersonality traitssupport programstype 2 diabetestypology

Identifiers

PMID35642243
PMCPMC9148599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.